Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 17, 2022

SELL
$11.05 - $12.72 $486 - $559
-44 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$10.61 - $12.88 $466 - $566
44 New
44 $1,000
Q4 2021

Jan 25, 2022

SELL
$10.86 - $13.95 $847 - $1,088
-78 Closed
0 $0
Q3 2021

Oct 26, 2021

BUY
$11.92 - $13.92 $929 - $1,085
78 New
78 $1,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $323M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Cordant, Inc. Portfolio

Follow Cordant, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordant, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cordant, Inc. with notifications on news.